UAE's Neopharma Gets Major Drug-Production Contract From Merck KGaA
This article was originally published in PharmAsia News
Executive Summary
Merck KGaA has signed an licensing arrangement with the UAE's Neopharma to produce the Germany drug maker's Euthyrox (levothyroxine) hormone treatment and its Glucophage (metformin) for diabetes.